Translational behavioral research in cancer genetics

Preventive Medicine

Volumn 26, Issue 5 II, 1997, Pages

  Lerman, Caryn ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cancer risk; Genetic testing; Health behavior

Indexed keywords

BEHAVIORAL SCIENCE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FUTUROLOGY; GENETIC COUNSELING; HUMAN; MOLECULAR GENETICS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 0030863919     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1997.0204     Document Type: Article

References (47)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal A, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, Bignell G, Lancaster J, Swift S, Gregory S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
3. Savitsky K, Sfez S, Tagle D, Ziv Y, Sartiel A, Collins FS, et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-32.
4. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987;316:1289-94.
5. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993;5:279-82.
6. Nystrom-Lahti M, Parsons R, Sistonen P, Pylkkanen L, Aaltonen LA, Leach FS, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary non-polyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 1994;55:659-65.
7. Peltomäki P, Aaltonen L, Sistonen P, Rylkkanen L, Mecklin JP, Jarvinen H, et al. Genetic mapping of a locus predisposing to human colorecal cancer. Science 1993;260:810-2.
8. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
9. Bodmer WF, Bailey C, Bodmer J, Bussey HJ, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
10. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994;343:692-5.
11. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
12. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993;52:678-701.
13. Liu B, Nicolaides C, Markowitz S, Willson JK, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 1995;9:48-55.
14. Collins FS. BRCA1 - lots of mutations, lots of dilemmas. N Engl J Med 1996;334:186-8.
15. American Society of Human Genetics Ad Hoc Committee. Statement of The American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 1994;55:ii-iv.
16. National Action Plan on Breast Cancer. Commentary on ASCO statement on genetic testing in cancer susceptibility. J Clin Oncol 1996;14:1738-40.
17. Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, et al. A model protocol for evaluating the behavioral and psychological effects of BRCA1 testing. J Natl Cancer Inst 1996;88:872-82.
18. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, et al. Controlled trial of pretest education approaches to enhance informed decision-making about BRCA1 gene testing. J Natl Cancer Inst 1997;89:148-57.
19. Struewing JP, Lerman C, Kase RG, Giambarressi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4:169-73.
20. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision-making and outcomes. JAMA 1996;275:1885-92.
21. Croyle RT, Smith KR, Botkin JF, Baty B, Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997;16:63-72.
22. National Center for Human Genome Research. Statement on DNA testing for presymptomatic identification of cancer risk. JAMA 1994;271:785.
23. Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993;269:1970-4.
24. Peshkin BN. Role of the genetic counselor in familial cancer. Oncology 1996;10:176-82. [Invited Commentary]
25. Moos RH, Moos BS. A typology of family social environments. Fam Process 1976;15:357-71.
26. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med 1996;2:1179-83.
27. Gamble VN. A legacy of distrust: African Americans and medical research. Am J Prev Med 1993;9:35-8.
28. Jensen AT. Environment, heredity and intelligence. Cambridge, MA: Harvard Educational Review, 1969.
29. Wilfond BS, Fost N. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 1990;263:2777-83.
30. Brown ML, Kessler LG. The use of gene tests to detect heredi-tary predisposition to cancer: economic considerations. J Natl Cancer Inst 1995;87:1131-6.
31. Bloch M, Fahy M, Fox S, Hayden MR. Predictive testing for Huntington disease. II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 1989;32:217-24.
32. Kershner MA, Hammond EA, Donnenfeld AE. Knowledge of genetics among residents in obstetrics and gynecology. Am J Hum Genet 1993;53:1356-8.
33. Wertz DC, Fletcher JC. Geneticists approach ethics: an international survey. Clin Genet 1993;43:104-10.
34. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 1995;85:1133-5.
35. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-92.
36. Craufurd D, Dodge A, Kerzin-Storrar L, Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989;2:603-5.
37. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
38. Black WC, Nease RF Jr, Tosteson ANA. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.
39. Rimer BK. Mammography use in the U.S.: trends and the impact of interventions. Ann Behav Med 1994;16:317-26.
40. Glanz K, Lerman C. Psychosocial impact of breast cancer: a critical review. Ann Behav Med 1992;14:204-12.
41. Baker SG, Freedman LS. Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst 1995;87:1137-44.
42. Amos CI, Caporaso NE, Weston A. Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev 1992;1:505-13.
43. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 1991;12:1197-201.
44. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases suceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
45. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
46. Collins AC. Genetic influences on tobacco use: a review of human and animal studies. Int J Addict 1990/1991;25:35-55.
47. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking - a study of male twins. N Eng J Med 1992;372:829-33.